PPARG and obesity due to melanocortin 4 receptor deficiency: The possible beneficial effect of favoring adipocyte differentiation in the treatment of obesity was in part already suggested by the positive outcome on insulin resistance of PPARγ agonists, which act, among others, by promoting adipogenesis.